相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health
Chelsea N. Fries et al.
NATURE NANOTECHNOLOGY (2021)
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan et al.
SCIENCE (2021)
A novel vaccine adjuvant based on straight polyacrylate potentiates vaccine-induced humoral and cellular immunity in cynomolgus macaques
Vincent Pavot et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Acute Allergic Reactions to mRNA COVID-19 Vaccines
Kimberly G. Blumenthal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives
Zimei Wu et al.
PHARMACEUTICAL RESEARCH (2021)
Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations
Nicholas G. Kounis et al.
VACCINES (2021)
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2
Yuyang Lei et al.
CIRCULATION RESEARCH (2021)
The Effect of a TLR4 Agonist/Cationic Liposome Adjuvant on Varicella-Zoster Virus Glycoprotein E Vaccine Efficacy: Antigen Presentation, Uptake, and Delivery to Lymph Nodes
Seo Ri Wui et al.
PHARMACEUTICS (2021)
An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery
Kailash C. Petkar et al.
PHARMACEUTICS (2021)
Distinct antibody and memory B cell responses in SARS-CoV-2 naive and recovered individuals after mRNA vaccination
Rishi R. Goel et al.
SCIENCE IMMUNOLOGY (2021)
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
Thai Thanh Hoang Thi et al.
VACCINES (2021)
Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination
Mark M. Painter et al.
IMMUNITY (2021)
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
Jackson S. Turner et al.
NATURE (2021)
Considerations for Size, Surface Charge, Polymer Degradation, Co-Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases
Christopher J. Genito et al.
ADVANCED NANOBIOMED RESEARCH (2021)
A guide to vaccinology: from basic principles to new developments
Andrew J. Pollard et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Nano-co-delivery of lipophosphoglycan with soluble and autoclaved leishmania antigens into PLGA nanoparticles: Evaluation of in vitro and in vivo immunostimulatory effects against visceral leishmaniasis
Ozlem Ayse Tosyali et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)
Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters
Michael K. Lo et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy Adults
Louis Fries et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Alginate-coated chitosan nanoparticles act as effective adjuvant for hepatitis A vaccine in mice
Nourhan H. AbdelAllah et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
A Bivalent, Spherical Virus-Like Particle Vaccine Enhances Breadth of Immune Responses against Pathogenic Ebola Viruses in Rhesus Macaques
Karnail Singh et al.
JOURNAL OF VIROLOGY (2020)
Biocompatible cationic solid lipid nanoparticles as adjuvants effectively improve humoral and T cell immune response of foot and mouth disease vaccines
Shuai Li et al.
VACCINE (2020)
A Self-Adjuvanted, Modular, Antigenic VLP for Rapid Response to Influenza Virus Variability
Jhanvi Sharma et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Dendrimers as efficient nanocarriers for the protection and delivery of bioactive phytochemicals
Mohammad Yousefi et al.
ADVANCES IN COLLOID AND INTERFACE SCIENCE (2020)
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
Ling Ni et al.
IMMUNITY (2020)
Development of PLGA-PEG-PLGA Hydrogel Delivery System for Enhanced Immunoreaction and Efficacy of Newcastle Disease Virus DNA Vaccine
Ying Gao et al.
MOLECULES (2020)
New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes
Mario Amacker et al.
NPJ VACCINES (2020)
Liposomes: Advancements and innovation in the manufacturing process
Sanket Shah et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Chitosan-based particulate systems for drug and vaccine delivery in the treatment and prevention of neglected tropical diseases
Sevda Senel et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
Barriers and Strategies of Cationic Liposomes for Cancer Gene Therapy
Chunyan Liu et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Engineered Nanoparticles for Cancer Vaccination and Immunotherapy
Marisa E. Aikins et al.
ACCOUNTS OF CHEMICAL RESEARCH (2020)
Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines
Ruoyu Cheng et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Design of Targeted Nanostructured Coordination Polymers (NCPs) for Cancer Therapy
Fernando Novio
MOLECULES (2020)
COVID-19 vaccine development and a potential nanomaterial path forward
Matthew D. Shin et al.
NATURE NANOTECHNOLOGY (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Applications and Limitations of Dendrimers in Biomedicine
Adriana Aurelia Chis et al.
MOLECULES (2020)
Trained Innate Immunity, Epigenetics, and Covid-19
Alberto Mantovani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy
Maria L. Guevara et al.
FRONTIERS IN CHEMISTRY (2020)
Adjuvantation of an Influenza Hemagglutinin Antigen with TLR4 and NOD2 Agonists Encapsulated in Poly(D,L-Lactide-Co-Glycolide) Nanoparticles Enhances Immunogenicity and Protection against Lethal Influenza Virus Infection in Mice
Amir Tukhvatulin et al.
VACCINES (2020)
Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice
Yan Zhao et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
A potent novel vaccine adjuvant based on straight polyacrylate
Marie Garinot et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS-X (2020)
Spontaneous, solvent-free entrapment of siRNA within lipid nanoparticles
Jayesh A. Kulkarni et al.
NANOSCALE (2020)
Liposome-Based Drug Delivery Systems in Cancer Immunotherapy
Zili Gu et al.
PHARMACEUTICS (2020)
Exosome-based immunotherapy: a promising approach for cancer treatment
Zhijie Xu et al.
MOLECULAR CANCER (2020)
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Sebastian Scioli Montoto et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Nanoparticle-Based Strategies to Combat COVID-19
Riddhiman Medhi et al.
ACS APPLIED NANO MATERIALS (2020)
Targeting folate receptor β positive tumor-associated macrophages in lung cancer with a folate-modified liposomal complex
Tie Yan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Immunological considerations for COVID-19 vaccine strategies
Mangalakumari Jeyanathan et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Immune Cell-Derived Exosomes in the Cancer-Immunity Cycle
Wei Yan et al.
TRENDS IN CANCER (2020)
Organic and inorganic nanoparticle vaccines for prevention of infectious diseases
Christopher Poon et al.
NANO EXPRESS (2020)
Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy
Marzieh Naseri et al.
ONCOIMMUNOLOGY (2020)
B cell memory: building two walls of protection against pathogens
Munir Akkaya et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Dendritic cell derived exosomes loaded with immunoregulatory cargo reprogram local immune responses and inhibit degenerative bone disease in vivo
Mahmoud Elashiry et al.
JOURNAL OF EXTRACELLULAR VESICLES (2020)
Nanoscale platforms for messenger RNA delivery
Bin Li et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2019)
Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy
Jun Xu et al.
BIOMATERIALS (2019)
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
Norbert Pardi et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor
Flavia Fontana et al.
ACS NANO (2019)
Single-dose Ag85B-ESAT6-loaded poly(lactic-co-glycolic acid) nanoparticles confer protective immunity against tuberculosis
Anshu Malik et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Targeted homology-directed repair in blood stem and progenitor cells with CRISPR nanoformulations
Reza Shahbazi et al.
NATURE MATERIALS (2019)
A Magnetic Nanovaccine Enhances Cancer Immunotherapy
Yugang Guo et al.
ACS CENTRAL SCIENCE (2019)
Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization
Ning Wang et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Xiaopin Duan et al.
NATURE COMMUNICATIONS (2019)
Multilamellar Vaccine Particle Elicits Potent Immune Activation with Protein Antigens and Protects Mice against Ebola Virus Infection
Yuchen Fan et al.
ACS NANO (2019)
111P Pilot study on the feasibility, safety and immunogenicity of a personalized neoantigen-targeted immunotherapy (NeoPepVac) in combination with anti-PD-1 or anti-PD-L1 in advanced solid tumors
S K Moerk et al.
ANNALS OF ONCOLOGY (2019)
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
Philip J. M. Brouwer et al.
NATURE COMMUNICATIONS (2019)
Poly(D,L-lactide-co-glycolide) Nanoparticles as Delivery Platforms for TLR7/8 Agonist-Based Cancer Vaccine
Hyunjoon Kim et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responses
Joseph D. Bazzill et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology
Mark T. Orr et al.
NPJ VACCINES (2019)
In vivo targeting of DNA vaccines to dendritic cells using functionalized gold nanoparticles
Suresh Kumar Gulla et al.
BIOMATERIALS SCIENCE (2019)
Immune checkpoint inhibitors in malignancy
Luke Ardolino et al.
AUSTRALIAN PRESCRIBER (2019)
Comparison and process optimization of PLGA, chitosan and silica nanoparticles for potential oral vaccine delivery
Muhammad K. Amin et al.
THERAPEUTIC DELIVERY (2019)
Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
Lina Liu et al.
MOLECULAR THERAPY (2018)
Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses
Nuria Climent et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer
Eva Zupancic et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis
Abdus Sabur et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Multirole of Liposomes in Therapy and Prevention of infectious Diseases
Roberto Nisini et al.
FRONTIERS IN IMMUNOLOGY (2018)
Virus-like particle vaccines: immunology and formulation for clinical translation
Braeden Donaldson et al.
EXPERT REVIEW OF VACCINES (2018)
Dendrimers: A versatile nanocarrier for drug delivery and targeting
Atul P. Sherje et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen et al.
NATURE (2018)
A Novel Human Papillomavirus 16 L1 Pentamer-Loaded Hybrid Particles Vaccine System: Influence of Size on Immune Responses
Chengcheng Jia et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens
Tamiru Negash Alkie et al.
PLOS ONE (2018)
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
Harm HogenEsch et al.
NPJ VACCINES (2018)
Monophosphoryl Lipid A Based Cationic Liposome Facilitates Vaccine Induced Expansion of Polyfunctional T Cell Immune Responses against Visceral Leishmaniasis
Amrita Das et al.
ACS APPLIED BIO MATERIALS (2018)
Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques
Sudhir Pai Kasturi et al.
JOURNAL OF VIROLOGY (2017)
Encapsulation of two different TLR ligands into liposomes confer protective immunity and prevent tumor development
Banu Bayyurt et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Innate Immune Activation by cGMP-AMP Nanoparticles Leads to Potent and Long-Acting Antiretroviral Response against HIV-1
Chukwuemika Aroh et al.
JOURNAL OF IMMUNOLOGY (2017)
MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
Christopher M. Coleman et al.
VACCINE (2017)
Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis
Pedro Cecilio et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Cellulose Acetate Phthalate and Antiretroviral Nanoparticle Fabrications for HIV Pre-Exposure Prophylaxis
Subhra Mandal et al.
POLYMERS (2017)
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines
Luis O. De Serrano et al.
JOURNAL OF NANOBIOTECHNOLOGY (2017)
Liposomal Formulations in Clinical Use: An Updated Review
Upendra Bulbake et al.
PHARMACEUTICS (2017)
Towards an evidence based approach for the development of adjuvanted vaccines
Derek T. O'Hagan et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Influence of Size and Shape on the Anatomical Distribution of Endotoxin-Free Gold Nanoparticles
Laura Talamini et al.
ACS NANO (2017)
Antigen recognition-triggered drug delivery mediated by nanocapsule-functionalized cytotoxic T-cells
R. Brad Jones et al.
BIOMATERIALS (2017)
Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growth
Jaina M. Patel et al.
BIOMATERIALS (2016)
To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
F. Danhier
JOURNAL OF CONTROLLED RELEASE (2016)
Adjuvant-Loaded Subcellular Vesicles Derived From Disrupted Cancer Cells for Cancer Vaccination
Alexander S. Cheung et al.
SMALL (2016)
Exosomal cancer immunotherapy is independent of MHC molecules on exosomes
Stefanie Hiltbrunner et al.
ONCOTARGET (2016)
A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease
Meagan A. Barry et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity
A. L. Silva et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
A Polyethylenimine-Containing and Transferrin-Conjugated Lipid Nanoparticle System for Antisense Oligonucleotide Delivery to AML
Yiming Yuan et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Mucosal Vaccine Development Based on Liposome Technology
Valentina Bernasconi et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
A Triple Co-Culture Model of the Human Respiratory Tract to Study Immune-Modulatory Effects of Liposomes and Virosomes
Rebecca A. M. Blom et al.
PLOS ONE (2016)
A Lipid Based Antigen Delivery System Efficiently Facilitates MHC Class-I Antigen Presentation in Dendritic Cells to Stimulate CD8+ T Cells
Mithun Maji et al.
SCIENTIFIC REPORTS (2016)
Effective polymer adjuvants for sustained delivery of protein subunit vaccines
Justin R. Adams et al.
ACTA BIOMATERIALIA (2015)
Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo
Zichao Luo et al.
BIOMATERIALS (2015)
The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice
Frank Wegmann et al.
CLINICAL AND VACCINE IMMUNOLOGY (2015)
Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity
D. Bento et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel
Sara A. Abouelmagd et al.
JOURNAL OF DRUG TARGETING (2015)
In situ Delivery of Tumor Antigen- and Adjuvant-Loaded Liposomes Boosts Antigen-Specific T-Cell Responses by Human Dermal Dendritic Cells
Martine A. Boks et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Design of Multifunctional Liposomal Nanocarriers for Folate Receptor-Specific Intracellular Drug Delivery
Min Hyung Kang et al.
MOLECULAR PHARMACEUTICS (2015)
Generation-Dependent Templated Self-Assembly of Biohybrid Protein Nanoparticles around Photosensitizer Dendrimers
Francesca Setaro et al.
NANO LETTERS (2015)
Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles
Rajesh Kumar et al.
VACCINE (2015)
M2e-immobilized gold nanoparticles as influenza A vaccine: Role of soluble M2e and longevity of protection
Wenqian Tao et al.
VACCINE (2015)
Correction: Combining Cationic Liposomal Delivery with MPL-TDM for Cysteine Protease Cocktail Vaccination against Leishmania donovani: Evidence for Antigen Synergy and Protection
Amrita Das et al.
PLoS Neglected Tropical Diseases (2015)
In vivo Gold Nanoparticle Delivery of Peptide Vaccine Induces Anti-Tumor Immune Response in Prophylactic and Therapeutic Tumor Models
Joao Paulo Mattos Almeida et al.
SMALL (2015)
Highly cited research articles in Journal of Controlled Release: Commentaries and perspectives by authors
Nicholas A. Peppas et al.
JOURNAL OF CONTROLLED RELEASE (2014)
The contribution of vaccination to global health: past, present and future
Brian Greenwood
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
Applications of nanomaterials as vaccine adjuvants
Motao Zhu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Drug Delivery Nanoparticles in Skin Cancers
Chiara Dianzani et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives
Yingying Xu et al.
Pharmaceutics (2014)
Engineering an Effective Immune Adjuvant by Designed Control of Shape and Crystallinity of Aluminum Oxyhydroxide Nanoparticles
Bingbing Sun et al.
ACS NANO (2013)
Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: Effect of mucoadhesive coating on antigen uptake and immune adjuvant activity
Dilip Pawar et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Influenza virosomes as vaccine adjuvant and carrier system
Christian Moser et al.
EXPERT REVIEW OF VACCINES (2013)
Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis
Zhenghong Xu et al.
JOURNAL OF CONTROLLED RELEASE (2013)
TLR agonists: our best frenemy in cancer immunotherapy
Sabina Kaczanowska et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Current trends in the use of liposomes for tumor targeting
Pranali P. Deshpande et al.
NANOMEDICINE (2013)
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Masaru Kanekiyo et al.
NATURE (2013)
Cationic lipids activate intracellular signaling pathways
Caroline Lonez et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases
Adriana Baz Morelli et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Dendritic Cell Targeted Chitosan Nanoparticles for Nasal DNA Immunization against SARS CoV Nucleocapsid Protein
Dharmendra Raghuwanshi et al.
MOLECULAR PHARMACEUTICS (2012)
Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine
James J. Moon et al.
PLOS ONE (2012)
Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction
James J. Moon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A systematic approach to exosome-based translational nanomedicine
Joshua L. Hood et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2012)
Vaccine development against Leishmania donovani
Amrita Das et al.
FRONTIERS IN IMMUNOLOGY (2012)
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial
Charles Butts et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine
Mehfuz Zaman et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Programming the magnitude and persistence of antibody responses with innate immunity
Sudhir Pai Kasturi et al.
NATURE (2011)
Vaccination of mice with chitosan nanogel-associated recombinant NcPDI against challenge infection with Neospora caninum tachyzoites
K. Debache et al.
PARASITE IMMUNOLOGY (2011)
Virosome-Formulated Plasmodium falciparum AMA-1 & CSP Derived Peptides as Malaria Vaccine: Randomized Phase 1b Trial in Semi-Immune Adults & Children
Patrick Georges Cech et al.
PLOS ONE (2011)
Potentiating Effects of MPL on DSPC Bearing Cationic Liposomes Promote Recombinant GP63 Vaccine Efficacy: High Immunogenicity and Protection
Saumyabrata Mazumder et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Mechanisms of tumor escape from the immune system: Adenosine-producing Treg, exosomes and tumor-associated TLRs
Theresa L. Whiteside et al.
BULLETIN DU CANCER (2011)
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
Ursula Wiedermann et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
A novel liposomal vaccine improves humoral immunity and prevents tumor pulmonary metastasis in mice
Zhenghua Zhong et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Cationic solid lipid nanoparticles loaded by cystein proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: Characterization and in vitro evaluations
Delaram Doroud et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Comparison of liposome based antigen delivery systems for protection against Leishmania donovani
Swati Bhowmick et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: Nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen
Bram Slutter et al.
VACCINE (2010)
Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
Luis M. Branco et al.
VIROLOGY JOURNAL (2010)
Vaccination Route That Induces Transforming Growth Factor β Production Fails To Elicit Protective Immunity against Leishmania donovani Infection
Sudipta Bhowmick et al.
INFECTION AND IMMUNITY (2009)
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years
B. Romanowski et al.
LANCET (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
Exosomes are an effective vaccine against congenital toxoplasmosis in mice
Celine Beauvillain et al.
VACCINE (2009)
Nanoparticles target distinct dendritic cell populations according to their size
Vania Manolova et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
A Virosomal Malaria Peptide Vaccine Elicits a Long-Lasting Sporozoite-Inhibitory Antibody Response in a Phase 1a Clinical Trial
Shinji L. Okitsu et al.
PLOS ONE (2007)
A Randomized Placebo-Controlled Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Synthetic Peptides in Healthy Adult Volunteers
Blaise Genton et al.
PLOS ONE (2007)
B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node
Yolanda R. Carrasco et al.
IMMUNITY (2007)
Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway
Samuel K. Lai et al.
BIOMATERIALS (2007)
Sentinel lymph node imaging using quantum dots in mouse tumor models
Byron Ballou et al.
BIOCONJUGATE CHEMISTRY (2007)
Direct exosome stimulation of peripheral human T cells detected by ELISPOT
Charlotte Admyre et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles
YJ Kwon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Lipid bilayer disruption by polycationic polymers: The roles of size and chemical functional group
A Mecke et al.
LANGMUIR (2005)
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
LL Villa et al.
LANCET ONCOLOGY (2005)
Influence of phospholipid composition on the adjuvanticity and protective efficacy of liposome-encapsulated Leishmania donovani antigens
T Mazumdar et al.
JOURNAL OF PARASITOLOGY (2005)
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
MA Morse et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity
L Bungener et al.
VACCINE (2005)
Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs
C Brignole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
分享论文
